{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T05:07:34Z","timestamp":1778908054541,"version":"3.51.4"},"reference-count":43,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,11,6]],"date-time":"2020-11-06T00:00:00Z","timestamp":1604620800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000871","name":"Mayo Clinic","doi-asserted-by":"publisher","award":["18-011482"],"award-info":[{"award-number":["18-011482"]}],"id":[{"id":"10.13039\/100000871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cjcopen.ca","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["CJC Open"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.cjco.2020.10.018","type":"journal-article","created":{"date-parts":[[2020,11,13]],"date-time":"2020-11-13T04:27:13Z","timestamp":1605241633000},"page":"318-326","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Von Willebrand Factor and ADAMTS13 as Predictors of Adverse Outcomes in Patients With Nonvalvular Atrial Fibrillation"],"prefix":"10.1016","volume":"3","author":[{"given":"Waldemar E.","family":"Wysokinski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rowlens M.","family":"Melduni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naser M.","family":"Ammash","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danielle T.","family":"Vlazny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ewa","family":"Konik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rayya A.","family":"Saadiq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Izabela","family":"Gosk-Bierska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua","family":"Slusser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diane","family":"Grill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert D.","family":"McBane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cjco.2020.10.018_bib1","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.0954-6820.1969.tb07351.x","article-title":"Atrial fibrillation: I. A study of atrial thrombosis and systemic embolism in a necropsy material","volume":"185","author":"Aberg","year":"1969","journal-title":"Acta Med Scand"},{"key":"10.1016\/j.cjco.2020.10.018_bib2","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1001\/archinte.1995.00430200078011","article-title":"Prevalence of residual left atrial thrombi among patients with acute thromboembolism and newly recognized atrial fibrillation","volume":"155","author":"Manning","year":"1995","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.cjco.2020.10.018_bib3","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1056\/NEJM200105103441901","article-title":"Assessment of cardioversion using transesophageal echocardiography investigators. Use of transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation","volume":"344","author":"Klein","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjco.2020.10.018_bib4","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/j.echo.2005.05.006","volume":"18","author":"Handke","year":"2005","journal-title":"J\u00a0Am Soc Echocardiogr"},{"key":"10.1016\/j.cjco.2020.10.018_bib5","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/S0894-7317(99)70105-7","article-title":"Pathophysiologic correlates of thromboembolism in nonvalvular atrial fibrillation: I. Reduced flow velocity in the left atrial appendage (The Stroke Prevention in Atrial Fibrillation [SPAF-III] Study)","volume":"12","author":"Goldman","year":"1999","journal-title":"J\u00a0Am Soc Echocardiogr"},{"key":"10.1016\/j.cjco.2020.10.018_bib6","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1016\/j.jacc.2004.11.071","article-title":"Patients with atrial fibrillation and dense spontaneous echo contrast at high risk a prospective and serial follow-up over 12 months with transesophageal echocardiography and cerebral magnetic resonance imaging","volume":"45","author":"Bernhardt","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjco.2020.10.018_bib7","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/S0735-1097(98)00146-6","article-title":"Transesophageal echocardiographic correlates of clinical risk of thromboembolism in nonvalvular atrial fibrillation. Stroke Prevention in Atrial Fibrillation III Investigators","volume":"31","author":"Zabalgoitia","year":"1998","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjco.2020.10.018_bib8","first-page":"1","article-title":"Venous thrombosis and the \u201cWessler\u201d test","volume":"76","author":"Thomas","year":"1996","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.cjco.2020.10.018_bib9","first-page":"218","article-title":"Early events in the formation of a venous thrombus following local trauma and stasis","volume":"51","author":"Schaub","year":"1984","journal-title":"Lab Invest"},{"key":"10.1016\/j.cjco.2020.10.018_bib10","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1161\/01.ATV.17.10.2238","article-title":"Remodeling with neointima formation in the mouse carotid artery after cessation of blood flow","volume":"17","author":"Kumar","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cjco.2020.10.018_bib11","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1136\/hrt.77.5.407","article-title":"Haemostatic and haemodynamic abnormalities associated with left atrial thrombosis in non-rheumatic atrial fibrillation","volume":"77","author":"Heppell","year":"1997","journal-title":"Heart"},{"key":"10.1016\/j.cjco.2020.10.018_bib12","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1136\/hrt.77.5.395","article-title":"Hypercoagulability and haemodynamic abnormalities in atrial fibrillation","volume":"77","author":"Lip","year":"1997","journal-title":"Heart"},{"key":"10.1016\/j.cjco.2020.10.018_bib13","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0735-1097(96)00427-5","article-title":"Atrial fibrillation activates platelets and coagulation in a time-dependent manner: a study in patients with paroxysmal atrial fibrillation","volume":"29","author":"Sohara","year":"1997","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjco.2020.10.018_bib14","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1161\/01.CIR.98.17.1721","article-title":"Increased expression of P-selectin on platelets is a risk factor for silent cerebral infarction in patients with atrial fibrillation: role of nitric oxide","volume":"98","author":"Minamino","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.cjco.2020.10.018_bib15","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0167-5273(00)00336-3","article-title":"Correlation between left atrial size, prothrombotic state and markers of endothelial dysfunction in patients with lone chronic nonrheumatic atrial fibrillation","volume":"75","author":"Mondillo","year":"2000","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cjco.2020.10.018_bib16","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1055\/s-0038-1650247","article-title":"Detection of hypercoagulable state in nonvalvular atrial fibrillation and the effect of anticoagulant therapy","volume":"75","author":"Mitusch","year":"1996","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.cjco.2020.10.018_bib17","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S0002-9149(00)01310-2","article-title":"Hemostatic state and atrial fibrillation (the Framingham Offspring Study)","volume":"87","author":"Feng","year":"2001","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjco.2020.10.018_bib18","series-title":"Von Willebrand Factor and the Mechanisms of Platelet Function","first-page":"79","article-title":"Biological functions of von Willebrand factor","author":"Ruggeri","year":"1998"},{"key":"10.1016\/j.cjco.2020.10.018_bib19","doi-asserted-by":"crossref","first-page":"41059","DOI":"10.1074\/jbc.C100515200","article-title":"Structure of von Willebrand factor-cleaving protease (ADAMTS13), a metalloprotease involved in thrombotic thrombocytopenic purpura","volume":"276","author":"Zheng","year":"2001","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.cjco.2020.10.018_bib20","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1161\/ATVBAHA.111.232991","article-title":"Left atrial blood stasis and Von Willebrand Factor-ADAMTS13 homeostasis in atrial fibrillation","volume":"31","author":"Ammash","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cjco.2020.10.018_bib21","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1161\/01.STR.30.12.2547","article-title":"Markers of thrombin and platelet activity in patients with atrial fibrillation: correlation with stroke among 1531 participants in the stroke prevention in atrial fibrillation III study","volume":"30","author":"Feinberg","year":"1999","journal-title":"Stroke"},{"key":"10.1016\/j.cjco.2020.10.018_bib22","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1161\/01.CIR.0000033220.97592.9A","article-title":"Plasma von Willebrand factor and soluble P-selectin as indices of endothelial damage and platelet activation in 1321 patients with non-valvular atrial fibrillation: relationship to stroke risk factors","volume":"106","author":"Conway","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.cjco.2020.10.018_bib23","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.1161\/01.CIR.0000077912.12202.FC","article-title":"Prognostic value of plasma von Willebrand factor and soluble P-selectin as indices of endothelial damage and platelet activation in 994 patients with nonvalvular atrial fibrillation","volume":"107","author":"Conway","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.cjco.2020.10.018_bib24","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1016\/j.jacc.2010.12.033","article-title":"Plasma von Willebrand factor levels are an independent risk factor for adverse events including mortality and major bleeding in anticoagulated atrial fibrillation patients","volume":"57","author":"Rold\u00e1n","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjco.2020.10.018_bib25","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1111\/eci.12140","article-title":"Prognostic role of plasma von Willebrand factor and soluble E-selectin levels for future cardiovascular events in a 'real-world' community cohort of patients with atrial fibrillation","volume":"43","author":"Krishnamoorthy","year":"2013","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.cjco.2020.10.018_bib26","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.ijcard.2012.09.056","article-title":"Prognostic value of plasma von Willebrand factor and its cleaving protease ADAMTS13 in patients with atrial fibrillation","volume":"168","author":"Freynhofer","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cjco.2020.10.018_bib27","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1007\/s00392-011-0337-9","article-title":"Biomarkers of structural remodelling and endothelial dysfunction for prediction of cardiovascular events or death in patients with atrial fibrillation","volume":"100","author":"Joachim","year":"2011","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.cjco.2020.10.018_bib28","doi-asserted-by":"crossref","first-page":"e11269","DOI":"10.1097\/MD.0000000000011269","article-title":"Prognostic value of von Willebrand factor in patients with atrial fibrillation: a meta-analysis","volume":"97","author":"Zhong","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.cjco.2020.10.018_bib29","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1136\/postgradmedj-2019-136842","article-title":"Prognostic value of von Willebrand factor for patients with atrial fibrillation: a meta-analysis of prospective cohort studies","volume":"96","author":"Ye","year":"2020","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.cjco.2020.10.018_bib30","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.echo.2007.01.016","article-title":"Does left atrial appendage peak emptying flow velocity predict the electrical energy required to achieve successful direct-current cardioversion in patients with persistent atrial fibrillation?","volume":"20","author":"Melduni","year":"2007","journal-title":"J\u00a0Am Soc Echocardiogr"},{"key":"10.1016\/j.cjco.2020.10.018_bib31","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.ahj.2009.12.043","article-title":"Predicting left atrial thrombi in atrial fibrillation","volume":"159","author":"Wysokinski","year":"2010","journal-title":"Am Heart J"},{"key":"10.1016\/j.cjco.2020.10.018_bib32","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/0735-1097(94)90644-0","article-title":"Relations between left atrial appendage blood flow velocity, spontaneous echocardiographic contrast and thromboembolic risk in\u00a0vivo","volume":"23","author":"Fatkin","year":"1994","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjco.2020.10.018_bib33","series-title":"The Echo Manual. Third Edition.","first-page":"109","article-title":"The Echo Manual. 3rd ed","author":"Oh","year":"2006"},{"key":"10.1016\/j.cjco.2020.10.018_bib34","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1378\/chest.09-1584","article-title":"Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro heart survey on atrial fibrillation","volume":"137","author":"Lip","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.cjco.2020.10.018_bib35","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.2337\/diacare.26.11.3160","article-title":"Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Follow-up report on the diagnosis of diabetes mellitus","volume":"26","author":"Genuth","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cjco.2020.10.018_bib36","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/0002-8703(84)90558-1","article-title":"International diagnostic criteria for acute myocardial infarction and acute stroke","volume":"108","author":"Gillum","year":"1984","journal-title":"Am Heart J"},{"key":"10.1016\/j.cjco.2020.10.018_bib37","doi-asserted-by":"crossref","first-page":"e257","DOI":"10.1161\/circ.114.4.257","volume":"114","author":"Fuster","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.cjco.2020.10.018_bib38","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","volume":"3","author":"Schulman","year":"2005","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.cjco.2020.10.018_bib39","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/S0735-1097(01)01125-1","article-title":"Increased von Willebrand factor in the endocardium as a local predisposing factor for thrombogenesis in overloaded human atrial appendage","volume":"37","author":"Fukuchi","year":"2001","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjco.2020.10.018_bib40","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1159\/000016023","article-title":"Cardioembolic vs. noncardioembolic strokes in atrial fibrillation: frequency and effect of antithrombotic agents in the stroke prevention in atrial fibrillation studies","volume":"10","author":"Hart","year":"2000","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.cjco.2020.10.018_bib41","doi-asserted-by":"crossref","first-page":"4235","DOI":"10.1182\/blood.V87.10.4235.bloodjournal87104235","article-title":"Physiologic cleavage of von Willebrand factor by a plasma protease is dependent on its conformation and requires calcium ion","volume":"87","author":"Tsai","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.cjco.2020.10.018_bib42","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.mayocp.2014.11.013","article-title":"The association between thromboembolic complications and blood group in patients with atrial fibrillation","volume":"90","author":"Blustin","year":"2015","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.cjco.2020.10.018_bib43","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1056\/NEJMoa032804","article-title":"C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease","volume":"350","author":"Danesh","year":"2004","journal-title":"N\u00a0Engl J Med"}],"container-title":["CJC Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589790X2030189X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589790X2030189X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T04:14:33Z","timestamp":1778904873000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589790X2030189X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S2589790X2030189X"],"URL":"https:\/\/doi.org\/10.1016\/j.cjco.2020.10.018","relation":{},"ISSN":["2589-790X"],"issn-type":[{"value":"2589-790X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Von Willebrand Factor and ADAMTS13 as Predictors of Adverse Outcomes in Patients With Nonvalvular Atrial Fibrillation","name":"articletitle","label":"Article Title"},{"value":"CJC Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cjco.2020.10.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Canadian Cardiovascular Society. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}